Regency Capital Management Inc.\DE recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
1001 BISHOP STREET HONOLULU, HI 96813
As of the latest 13F report, the guru’s equity portfolio contained 32 stocks valued at a total of $87.00Mil. The top holdings were
According to GuruFocus data, these were Regency Capital Management Inc.\DE’s top five trades of the quarter.
iShares Core S&P 500 ETF
During the quarter, Regency Capital Management Inc.\DE bought 13,679 shares of ARCA:IVV for a total holding of 15,519. The trade had a 6.04% impact on the equity portfolio. During the quarter, the stock traded for an average price of $384.6.
On 01/27/2023, iShares Core S&P 500 ETF traded for a price of $407.3706 per share and a market cap of $306.14Bil. The stock has returned -4.39% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares Core S&P 500 ETF has a price-earnings ratio of 20.15 and a price-book ratio of 3.80.
Aura Biosciences Inc
During the quarter, Regency Capital Management Inc.\DE bought 329,732 shares of NAS:AURA for a total holding of 554,286. The trade had a 3.98% impact on the equity portfolio. During the quarter, the stock traded for an average price of $12.73.
On 01/27/2023, Aura Biosciences Inc traded for a price of $10.16 per share and a market cap of $376.32Mil. The stock has returned -42.74% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Aura Biosciences Inc has a price-book ratio of 2.59 and a EV-to-Ebitda ratio of -5.29.
Markel Corp
The guru sold out of their 2,109-share investment in NYSE:MKL. Previously, the stock had a 2.8% weight in the equity portfolio. Shares traded for an average price of $1237.05 during the quarter.
On 01/27/2023, Markel Corp traded for a price of $1408.335 per share and a market cap of $18.94Bil. The stock has returned 19.14% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Markel Corp has a price-book ratio of 1.62, a EV-to-Ebitda ratio of 43.97 and a price-sales ratio of 1.68.
The price-to-GF Value ratio is 1.13, earning the stock a GF Value rank of 3.
iShares Gold Trust
The guru sold out of their 65,695-share investment in ARCA:IAU. Previously, the stock had a 2.54% weight in the equity portfolio. Shares traded for an average price of $32.84 during the quarter.
On 01/27/2023, iShares Gold Trust traded for a price of $36.52 per share and a market cap of $28.00Bil. The stock has returned 6.94% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares Gold Trust has a price-book ratio of 6.59.
Charles Schwab Corp
During the quarter, Regency Capital Management Inc.\DE bought 23,647 shares of NYSE:SCHW for a total holding of 28,739. The trade had a 2.26% impact on the equity portfolio. During the quarter, the stock traded for an average price of $77.61.
On 01/27/2023, Charles Schwab Corp traded for a price of $78.81999999999999 per share and a market cap of $147.14Bil. The stock has returned -11.65% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Charles Schwab Corp has a price-earnings ratio of 22.52, a price-book ratio of 5.53, a price-earnings-to-growth (PEG) ratio of 1.05 and a price-sales ratio of 7.20.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 5.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
